Stay updated with breaking news from Hamilton Bennett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
McGill University has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. McGill is
Gilsinan alternates her subjects’ stories over time, compelling the reader to turn the pages to find out what happens to them.
Covid-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet, how did Moderna know that COVID-19 would create those conditions months before anyone else, and why did they later claim that their vaccine being tested in NIH trials was different than their commercial candidate? In late 2019, the biopharmaceutical company Moderna was facing a series of challenges that not only threatened its ability to ever take a product to market, and thus turn a profit, but its very existence as a company. There were multiple warning signs that Moderna was essentially a...
The best uncensored news, information, and analysis.
By James Rosen LIKE SO MANY other Americans, I cheered in awe and happy disbelief last year as a band of driven, brainy scientists worked at breakneck speed to develop a vaccine to stop a pandemicâs deadly rampage across the globe. Sacrificing sleep, foregoing family time, fueled by adrenaline and hope, a small group of immunologists and virologists collaborated across borders to achieve the impossible: create a new type of vaccine from scratch in a fraction of the time previously required to create the inoculations that had conquered past pandemics. They didnât have the...